Testing effectiveness (Phase 2)Study completedNCT00688623
What this trial is testing
RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Who this might be right for
Advanced and Metastatic Silent Neuro-Endocrine TumorsCarcinomaNeuroendocrine+4 more
Novartis Pharmaceuticals 73